Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Deferred Taxes: 2010-2024

Historic Deferred Taxes for Cryo Cell International (CCEL) over the last 12 years, with FY2024 value amounting to -$309274.0.

  • Cryo Cell International's Deferred Taxes rose 1291.33% to -$738772.0 in Q4 2018 from the same period last year, while for Nov 2018 it was $2.4 million, marking a year-over-year increase of 20234.0%. This contributed to the annual value of -$309274.0 for FY2024, which is 9541.84% up from last year.
  • Per Cryo Cell International's latest filing, its Deferred Taxes stood at -$309274.0 for FY2024, which was up 9541.84% from -$6.8 million recorded in FY2023.
  • Cryo Cell International's 5-year Deferred Taxes high stood at -$309274.0 for FY2024, and its period low was -$6.8 million during FY2023.
  • Its 5-year average for Deferred Taxes is -$2.3 million, with a median of -$1.6 million in 2021.
  • Its Deferred Taxes has fluctuated over the past 5 years, first plummeted by 28968.32% in 2023, then soared by 9541.84% in 2024.
  • Cryo Cell International's Deferred Taxes (Annual) stood at -$1.3 million in 2020, then fell by 28.21% to -$1.6 million in 2021, then decreased by 5.23% to -$1.7 million in 2022, then tumbled by 289.68% to -$6.8 million in 2023, then soared by 95.42% to -$309274.0 in 2024.
  • Its Deferred Taxes was -$309274.0 in FY2024, compared to -$6.8 million in FY2023 and -$1.7 million in FY2022.